Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment (DEMETER - SIRIO 11) Study

NCT05905965 is registered in ClinicalTrials.gov with Collegium Medicum w Bydgoszczy as lead sponsor.

NCT NCT05905965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05905965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment (DEMETER - SIRIO 11) Study
Lead sponsor
Collegium Medicum w Bydgoszczy
Phase
Phase 3
Overall status
Recruiting
Start date
May 1, 2023
Completion date
March 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome